i n g c a p a c i t i e s and low w h i t e c e l l C l e v e l s when measured by s t a ndard techniques.
" f r e e Fe" m i g h t be a p a r t i c u l a r l y p o t e n t o x i d a n t and t h e r e f o r e r e s p o n s i b l e f o r some o f t h e patholoqy i n t h a l , and s i n c e C i s thought t o increase t h e r a t e o f t r a n s f e r o f Fe from one pool t o another, we examined 5 o f these p a t i e n t s t o determine t h e e f f e c t o f C and DF on " f r e e Fe". A l l 5 t h a l s had low i n i t i a l w h i t e c e l l C l e v e l s . Each r e c e i v e d a l t e r n a t i n g 12-hour continuous I . V . r e gimens o f C alone, s a l i n e , and C + DF w i t h samples f o r " f r e e Fe" d r a m e v e r y 4 hours. Results showed t h a t " f r e e Fe" was 9.8f2.3 pg% d u r i n g a a l i n e i n f u s i o n s and t h a t the,,level was unchanged when C was added. When DF was present, f r e e Fe" was e l i m i n a t e d . These r e s u l t s show t h a t t h a l s w i t h Fe o v e r l o a d have measurable = amounts o f " f r e e Feu which a r e n o t a f f e c t e d by C. Continuous c h e l a t i o n w i t h DF i s e f f e c t i v e i n e l i m i n a t i n g t h i s p o t e n t i a l l y t o x i c p o o l . Forty-seven of 417 evaluable patients (11%) developed hematuria. The hematuria was moderate or severe in 80% of cases. It occurred with equal frequency throughout treatment and occurred for the first time in some patients after therapy was stopped. Severe neutropenia (<500/mm3) was observed in 67% of patient in Regimen E and 72% of patients in Regimen F (Clinical Groups I11 and IV). Adriamycin cardiomyopathy has not been observed in this study.
Since most early deaths occurred in patients with head and neck primaries, the use of less intensive initial chemotherapeutic regimens may be advisable fo these patients. The purpose of this study was to investigate the cause of granulocytopenia in children with acute lymphocytic leukemia (ALL). The double layer agar technique for myeloid colony formation was utilized in a1 studies. Various concentrations of sera from 16 chi1 dren with ALL at the time of diagnosis were added to bone marrow cells in culture. Only 2 sera were observed to produce inhibition of colony formation. Various concentrations of initial bone marrow cells from children with ALL were mixed with normal bone marrow cells and cultured. No inhibition of colony formation was observed in agar. To circumvent any effect of HL-A antigens, initial bone marrow cells from children with ALL were frozen in liquid nitrogen After a remission bone marrow was obtained, the initial and remission bone marrow cells were mixed an( cultured together. No inhibition of colony formation was observed.
HE EFFECT OF SERUM AND BLAST CELLS FROM
It may be concluded that the neutropenia observed in children with ALL at diagnosis is not due to serum factors or inhibition by leukemic cells. Twenty-six children with gross residual (18) or metastatic (8) rhabdomyosarcoma were treated with pulse-VAC (Vincristine weekly x 11 plus actinomycin D and cyclophosphamide simultaneously for 5 days) and radiotherapy. Toxicity during the 12-week induction period included 22/26 pat'ents (85%) with an absolute 3 neutrophil count (ANC) under 500/mm ; 15/26 (58%) received intravenous antibiotics. Three developed Gram-negative sepsis and 2 of them died. In 25 patients followed 12 weeks, there were 4 complete responses (CR) and 5 partial responses (PR), a total of 36%. At 12 weeks 6 patients randomly received intermittent pulse-VAC (Regimen H) and 9 received pulse-VAC alternating with Adriamycin (Reg. I ) . After this pulse, 7/15 (47%) had a low ANC; none had severe infection and only 3 received antibiotics. Severe toxicity disappeared with subsequent dose reduction. To date, CR rate averages 48%, 36% on Reg. H and 58% on Reg. I; the overall partial response rate is 26%. However 517 CR patients on Reg. I had an orbital primary. Despite increased toxicity, these regimens are no better than current IRS schedule for advanced disease. Introducing adriamycin before 12 weeks ma deserve trial in attemptina to improve the response rate. 
N E U R O P S Y C H O L O G I C A L L A T E S E Q U E L A E O

l a s t s grown i n t h e presence o f methot r e x a t e (MTX) accumulated t h e druq and metabolized i t t o p o l y -yglutamyl m e t a b o l i t e s (polyqlutamates)
. A f t e r 15 rnin i n c u b a t i o n i n 1 pM MTX, t h e n o n -d i f f u s a b l e component o f MTX i n these c e l l s was 58 pg MTX equivalent/mg c e l l p r o t e i n , none o f which c o n s i s t e o f polyqlutamates. Accumulation o f polyglutamates was l i n e a r w i t h t i m e so t h a t a f t e r 6 h t h e c e l l s contained 285 pg/mq o f which 45 pg/mg was MTX, 162 oq/ma was MTX monoqlutamate and 78 pg/mq was MTX d i g l u t a m a t e . I t has been sugqested t h a t t h e cont i n u e d presence o f a component o f i n t r a c e l l u l a r MTX i n excess o f t h a t bound t o i n t r a c e l l u l a r b i n d e r s i s r e q u i r e d f o r t h e i n h i b it i o n by MTX o f deoxyuridine (dU) i n c o r p o r a t i o n i n t o DNA. When f i b r o b l a s t s were preincubated f o r 1 h i n 1 pM MTX-containing medium and then t r a n s f e r r e d i n t o MTX-free medium, t h e r e was comolete recoverv o f t h e i r a b i l i t v t o i n c o r~o r a t e dU i n t o DNA. However when t h e p r e -i n c u b a t i o n was increased t o 4 and 6 h, t h e 24 h i n c o r p o r a t i o n o f dU decreased from 65.5 nM dU/qrn c e l l prot e i n t o 17.5 and 4.9 nM/gm r e s p e c t i v e l y . Thus i n h i b i t i o n by MTX o f dU i n c o r p o r a t i o n i n t o DNA a f t e r t h e l o n g e r i n c u b a t i o n s was no dependent on the continued presence of MTX in the culture medium and was associated w i t h a r i s e b o t h i n t o t a l i n t r a c e l l u l a r MTX d e r i v a t i v e s and most p a r t i c u l a r l y i n MTX polyglutamates.
